New Delhi, April 7 Biocon Ltd announced on Tuesday the commercial launch of biosimilars Bosaya and Aukelso, indicated for different serious bone conditions, in the US.Bosaya (a biosimilar to Prolia) and Aukelso (a biosimilar to Xgeva) are now available by prescription nationwide through...
Ranchi, March 10 The industry-led, non-profit organization, IFQM, stated on Tuesday that strengthening collaboration between industry and academia to achieve the goal of the 'Viksit Bharat 2047' vision is its critical national priority.Conglomerates such as the Tata Group, Larsen & Toubro...
biocon
bml munjal university
boeing india
ifqm
india
industry-academia collaboration
larsen & toubro
nit jamshedpur
quality management
siom nashik
student-led quality clubs
sun pharma
talent development
tata group
viksit bharat 2047
xlri jamshedpur
New Delhi, February 20 Biocon Chairperson Kiran Mazumdar-Shaw said on Friday that the convergence of biological intelligence and artificial intelligence (AI) can drive a paradigm shift in medicine, enabling breakthroughs in predictive healthcare, regenerative science, and lifespan management...
artificial intelligence
biocon
biology
cell reprogramming
community care
convergent technology
data sharing
digital infrastructure
healthcare
india
kiran mazumdar-shaw
lifespan management
predictive healthcare
regenerative science
New Delhi, February 12 Biocon announced on Thursday a more than five-fold increase in consolidated net profit to Rs 144 crore for the quarter ended December 2025, driven by gains in its generics and biosimilar business segments.The Bengaluru-based company reported a net profit of Rs 25 crore...